Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Guanethidine monosulfate
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Ganda 1 + 0.2 eye drops
1106000S0BCAAAE
|
Ganda | Guanethidine monosulfate | Eye | No data available |
|
Ganda 3 + 0.5 eye drops
1106000S0BCABAF
|
Ganda | Guanethidine monosulfate | Eye | No data available |
|
Guanethidine 1% / Adrenaline 0.2% eye drops
1106000S0AAAEAE
|
Guaneth monosulfate (Eye) | Guanethidine monosulfate | Eye | No data available |
|
Guanethidine 10mg/1ml solution for injection ampoules
0205030N0AAAAAA
|
Guaneth monosulfate (Systemic) | Guanethidine monosulfate | Cardiovascular System | No data available |
|
Guanethidine 3% / Adrenaline 0.5% eye drops
1106000S0AAAFAF
|
Guaneth monosulfate (Eye) | Guanethidine monosulfate | Eye | No data available |
|
Ismelin 10mg/1ml solution for injection ampoules
0205030N0BBACAA
|
Ismelin (Systemic) | Guanethidine monosulfate | Cardiovascular System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.